content

Embracing AI as a tool in small molecule drug production

Over the last 10 years, drug developers have increasingly utilized artificial intelligence (AI) in small molecule drug development and manufacturing. From applying machine learning...

Hyperparathyroidism: Symptoms, Causes and Treatment

Hyperparathyroidism is an extremely prevalent endocrine disorder. Recent studies reveal that about 80% of people in Western countries suffer from parathyroids. Additionally, about 1,00,000...

Canadian And US Pharma Firms To Test Psychedelic Drugs In UK

To take advantage of the UK's quick medication approval procedures, the North American psychedelic drug companies Mindset, PharmAla, Mydecine, and Psyence have inked a...

Aseptic Filling: Selecting the Right CDMO Partner

For companies in the early stages of developing a new parenteral therapy, the focus within the product teams is naturally on the molecule and...

Swiss and French Health Authorities Expand Recommendations for Use of Nuvaxovid COVID-19 Vaccine as a Booster

Novavax announced that Switzerlandโ€™s Federal Office of Public Health (FOPH) and Franceโ€™s Haute Autoritรฉ de Santรฉ (HAS) have expanded their recommendations for use of...

Evaxion and ExpreS2ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate

Evaxion Biotech A/S , a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies,ย  announces that the Company has signed a Vaccine Discovery...

Pfizer and BioNTech Receive U.S. FDA EUA for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years

Pfizer Inc. and BioNTech SE announced the U.S. FDA granted Emergency Use Authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read